Tesamorelin Storage — Stability, Reconstitution & Cold Chain Maintenance

Most tesamorelin protocols fail at the storage stage. Not the injection stage. A single temperature excursion above 8°C during shipping or at home can denature the protein structure entirely, turning an effective compound into an expensive saline injection. The gap between a stable, potent peptide and a degraded vial comes down to cold chain management. Before, during, and after reconstitution.

We've guided hundreds of researchers through this exact process. The difference between doing it right and doing it wrong comes down to three things most protocols never mention: pre-reconstitution freezer storage at −20°C, strict 2–8°C refrigeration post-mixing, and the 28-day viability window that begins the moment bacteriostatic water contacts the lyophilised powder.

What is the correct way to store tesamorelin before and after reconstitution?

Tesamorelin storage requires −20°C freezer conditions for unreconstituted lyophilised powder, with a shelf life of up to 36 months when properly sealed. Once reconstituted with bacteriostatic water, tesamorelin must be refrigerated at 2–8°C and used within 28 days. Any temperature excursion above 8°C causes irreversible aggregation of the peptide chains, rendering the compound ineffective regardless of appearance.

Yes, tesamorelin must be stored cold. But the temperature requirement differs sharply before and after mixing. Lyophilised tesamorelin peptide is a freeze-dried powder with minimal moisture content, which grants stability at subzero temperatures. Once reconstituted, the peptide is suspended in solution where thermal motion, pH shifts, and oxidative stress can all degrade the growth hormone-releasing hormone (GHRH) analogue structure. This article covers exactly how tesamorelin storage works at each stage, what temperature ranges preserve potency, and what preparation mistakes negate stability entirely.

Understanding Tesamorelin Peptide Structure and Storage Requirements

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), consisting of 44 amino acids with a trans-3-hexenoic acid modification at the N-terminus. This modification extends the peptide's half-life to approximately 26–38 minutes in vivo, but the compound remains highly sensitive to environmental stressors. Temperature, light, pH, and mechanical agitation all accelerate degradation.

Lyophilised tesamorelin peptide is supplied as a sterile, white-to-off-white powder in sealed vials under vacuum or inert gas. In this freeze-dried state, the peptide exhibits exceptional stability. Manufacturer data indicates shelf life of 24–36 months when stored at −20°C and protected from light. The lyophilisation process removes water content to below 3%, which dramatically slows hydrolysis and oxidation reactions that would otherwise cleave peptide bonds or oxidise methionine residues.

Once reconstituted with bacteriostatic water (0.9% benzyl alcohol), tesamorelin becomes vulnerable. The peptide is now in aqueous solution at physiological or near-physiological pH, where thermal energy drives molecular motion and increases the probability of aggregation. The irreversible clumping of peptide chains into non-functional oligomers. This aggregation is accelerated above 8°C and becomes catastrophic above 25°C. Research published in the Journal of Pharmaceutical Sciences demonstrates that peptide aggregation rates double with every 10°C increase in storage temperature. A vial left at room temperature (22°C) for 24 hours experiences aggregation equivalent to two weeks of refrigerated storage.

The 28-day post-reconstitution window is not arbitrary. Studies on GHRH analogues show that even under optimal refrigeration (2–8°C), peptide potency declines by approximately 1–2% per week due to slow oxidation and deamidation. By day 28, cumulative loss reaches 8–10%, which is the threshold where dose accuracy becomes unreliable. At Real Peptides, we emphasize this timeline because researchers often assume refrigeration alone preserves indefinite stability. It doesn't. The clock starts the moment bacteriostatic water enters the vial.

Tesamorelin storage also demands protection from light. UV and visible light catalyse photodegradation of tryptophan and tyrosine residues, which can alter the peptide's tertiary structure and reduce receptor binding affinity. Amber glass vials or opaque secondary packaging mitigate this risk, but vials should never be stored on open refrigerator shelves exposed to interior lighting.

Proper Tesamorelin Storage Before Reconstitution

Unreconstituted tesamorelin peptide demands strict freezer storage at −20°C. This temperature arrests nearly all chemical degradation pathways. Hydrolysis, oxidation, and deamidation. By reducing molecular kinetic energy to near-zero levels. Lyophilised peptides stored at −20°C maintain 95–98% potency for up to 36 months, provided the vial seal remains intact and moisture infiltration is prevented.

Freeze-thaw cycles are the single greatest threat to pre-reconstitution tesamorelin storage. Each thaw event allows residual moisture in the peptide powder to shift from solid to liquid phase, which increases local hydrolysis rates. Refreezing does not reverse this damage. It compounds it. Researchers who remove vials from the freezer for inspection and return them repeatedly can lose 10–15% potency before the first reconstitution. The protocol is simple: store at −20°C, remove once when ready to reconstitute, and never refreeze.

Ambient temperature tolerance for lyophilised tesamorelin is limited. Manufacturer stability data indicates that sealed vials can tolerate up to 72 hours at room temperature (20–25°C) without significant degradation. This buffer accommodates standard shipping delays. However, temperatures above 30°C accelerate degradation exponentially. A vial exposed to 35°C for 48 hours (common in summer shipping without cold packs) may lose 15–25% potency before it ever reaches the researcher.

At Real Peptides, we ship all lyophilised peptides. Including Tesamorelin Peptide. With medical-grade cold packs and insulated packaging rated for 48-hour transit. Vials are packed at 2–8°C and remain within that range throughout shipping. Upon receipt, vials should be transferred immediately to a −20°C freezer if not reconstituting within 24 hours. If reconstituting immediately, refrigeration at 2–8°C is sufficient while preparing bacteriostatic water and reconstitution supplies.

Storage location within the freezer matters. Avoid door shelves. Door opening and closing introduces temperature fluctuations. Place vials in the back center of the freezer where temperature remains most stable. If storing multiple peptides, group them in a sealed container (not airtight. Allow airflow) to minimize frost accumulation on individual vials.

Moisture infiltration is the second major risk. If the vial seal is compromised. Even microscopically. Humid air enters the vial and condenses on the peptide powder. This moisture initiates hydrolysis immediately. Inspect vials upon receipt: the rubber stopper should be fully seated, the aluminum crimp seal intact, and the powder should be uniformly white or off-white with no clumping. Any clumping indicates prior moisture exposure. Do not use that vial.

Tesamorelin Storage After Reconstitution: Refrigeration and Viability

Once tesamorelin is reconstituted with bacteriostatic water, tesamorelin storage requirements shift to strict refrigeration at 2–8°C. At this temperature range, molecular motion is slowed but not halted. Slow oxidation and deamidation continue, which is why the 28-day viability window exists. Reconstituted tesamorelin stored above 8°C begins aggregating within hours, and aggregation is irreversible.

Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth but does not prevent peptide degradation. The benzyl alcohol maintains sterility for up to 28 days in a multi-dose vial, provided aseptic technique is followed during each draw. After 28 days, both peptide potency and sterility assurance decline, which is why reconstituted tesamorelin should never be used beyond this window regardless of refrigeration.

Refrigerator placement is critical. Store reconstituted vials in the main body of the refrigerator. Not the door, where temperature fluctuates with opening and closing. The back center shelf maintains the most stable 2–8°C range. Avoid placing vials near the rear wall where temperatures can drop below 2°C. Freezing reconstituted peptides causes ice crystal formation, which ruptures peptide structures irreversibly.

Temperature excursions above 8°C are catastrophic. A reconstituted vial left at room temperature (22°C) for 4 hours experiences aggregation equivalent to one week of refrigerated storage. If a vial is accidentally left out overnight (8+ hours), assume total loss. There is no way to visually confirm potency, and the risk of injecting aggregated peptide is unacceptable. We've seen researchers attempt to "salvage" vials by refrigerating them after prolonged room temperature exposure. This does not reverse aggregation.

Light exposure remains a concern post-reconstitution. Reconstituted tesamorelin should be stored in its original amber vial or wrapped in aluminum foil if transferred to a clear vial. Refrigerator interior lighting is sufficient to catalyse photodegradation over 28 days. Opaque secondary packaging (a small box or opaque bag) is advisable.

Multiple-draw contamination risk increases with each needle puncture through the rubber stopper. Use a fresh, sterile needle for every draw. Never reuse needles. Wipe the stopper with an alcohol pad before each puncture and allow it to air-dry for 10 seconds. Inject air into the vial equal to the volume you plan to withdraw. This prevents vacuum formation, which can pull contaminants back through the needle track.

At Real Peptides, our Bacteriostatic Water is USP-grade and supplied in sealed, sterile vials to ensure aseptic reconstitution. Proper tesamorelin storage begins with proper reconstitution. Using non-sterile or expired bacteriostatic water introduces contamination that no amount of refrigeration can mitigate.

Tesamorelin Storage: Lyophilised vs Reconstituted Comparison

Tesamorelin storage requirements differ sharply depending on the peptide's state. The table below compares stability, temperature requirements, and viability windows for lyophilised versus reconstituted tesamorelin.

The lyophilised state offers the longest stability window, but that window closes permanently once reconstitution occurs. Researchers who reconstitute entire multi-dose vials and then fail to use them within 28 days lose the unused portion. Partial reconstitution is not feasible with standard vial formats.

Key Takeaways

• Tesamorelin storage requires −20°C freezer conditions for unreconstituted lyophilised powder, with a shelf life of 24–36 months when sealed and protected from freeze-thaw cycles.
• Once reconstituted with bacteriostatic water, tesamorelin must be refrigerated at 2–8°C and used within 28 days. This timeline reflects cumulative oxidation and deamidation that occurs even under optimal refrigeration.
• Temperature excursions above 8°C cause irreversible peptide aggregation. A reconstituted vial left at room temperature for 4+ hours should be discarded regardless of appearance.
• Freeze-thaw cycles on unreconstituted vials accelerate hydrolysis and can reduce potency by 10–15% before the first reconstitution. Remove vials from the freezer only once, when ready to use.
• Light exposure catalyses photodegradation of tryptophan and tyrosine residues. Store both lyophilised and reconstituted vials in amber glass or opaque secondary packaging.
• Bacteriostatic water's 0.9% benzyl alcohol maintains sterility for 28 days but does not prevent peptide degradation. The 28-day window is a combined stability and sterility limit.

What If: Tesamorelin Storage Scenarios

What If I Accidentally Left Reconstituted Tesamorelin at Room Temperature Overnight?

Discard the vial. Eight hours at 22°C accelerates aggregation equivalent to one full week of refrigerated storage. Even if the solution appears clear, aggregated peptides can still be present in concentrations that render the dose unreliable. No home test exists to confirm potency post-excursion. The financial loss is smaller than the research integrity risk of using compromised material.

What If My Freezer Experienced a Power Outage While Storing Lyophilised Tesamorelin?

Check the duration and peak temperature reached. If the outage lasted fewer than 4 hours and the freezer remained below 0°C, the peptide is likely stable. If the freezer reached 10°C or higher for more than 6 hours, assume partial degradation. Potency loss of 10–20% is probable. If the vial thawed completely and remained above 15°C for 12+ hours, discard it. Lyophilised peptides tolerate brief ambient exposure but not prolonged thermal stress.

What If I Need to Transport Reconstituted Tesamorelin Between Locations?

Use a medical-grade insulin cooler or portable refrigerator rated for 2–8°C. Standard ice packs in a soft-sided cooler are insufficient. They often drop below 0°C (freezing risk) or rise above 10°C once the ice melts. FRIO wallets use evaporative cooling and maintain 2–8°C for 36–48 hours without refrigeration, but they require activation (soaking in water) 10 minutes before use. For same-day transport under 4 hours, a pre-chilled insulated container with a calibrated gel pack works. Verify the internal temperature with a thermometer before placing the vial inside.

What If the Lyophilised Powder Appears Clumped or Discolored Upon Arrival?

Do not reconstitute. Clumping indicates prior moisture infiltration, and discoloration (yellow, brown, or gray tint) signals oxidation or thermal degradation. Contact the supplier immediately. Reputable sources like Real Peptides replace compromised vials at no cost. Using a degraded vial compromises the entire research protocol and invalidates any results obtained.

The Unfiltered Truth About Tesamorelin Storage

Here's the honest answer: tesamorelin storage is unforgiving. The margin between a stable, potent peptide and a degraded one is narrower than most researchers assume. There is no visual cue, no smell, no cloudiness that reliably signals partial degradation. A vial stored incorrectly can appear perfectly clear while containing 30% aggregated peptide and 70% active compound. You won't know until you compare results against properly stored controls, and by then the protocol is compromised.

The 28-day post-reconstitution window is not conservative. It's evidence-based. Researchers who extend this timeline to 35 or 40 days because "the vial still looks fine" are gambling with dose accuracy. Slow oxidation and deamidation are invisible, and potency loss accelerates non-linearly after day 28. The financial cost of discarding unused reconstituted peptide is lower than the research integrity cost of using peptide of unknown potency.

Freeze-thaw cycles are not "mostly harmless". They're cumulative. Every thaw event degrades the peptide incrementally, and the damage stacks. A vial frozen and thawed three times before reconstitution starts at 85–90% potency instead of 98%. That 10–15% loss is enough to skew dose-response curves and introduce variability that no statistical correction can account for.

The bottom line: if you're serious about tesamorelin research, cold chain management is not optional. It's the foundation. Storage errors are the most common source of irreproducible results in peptide research, and they're also the easiest to prevent. A $40 medical-grade cooler and a $15 thermometer eliminate 90% of the risk.

For researchers exploring other peptides alongside tesamorelin, understanding storage principles applies broadly. Compounds like Ipamorelin and Sermorelin share similar cold chain requirements, and the same discipline that preserves tesamorelin potency extends across your entire research protocol. Explore the full range of research-grade peptides designed for precision and reliability at Real Peptides.

If the storage requirements concern you, address them before ordering. Specifying cold chain shipping, confirming freezer capacity, and sourcing medical-grade transport coolers costs nothing upfront and matters across every vial you'll ever handle. Proper tesamorelin storage isn't about caution. It's about respecting the compound's structure and the research integrity it enables.